Etesian Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Etesian Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$352K	Sell	702 -64	-8%	-$30.7K	0.1%	107
2026 Q1	$377K	Hold	766	–	–	0.12%	103
2025 Q4	$444K	Sell	766 -20	-3%	-$11.3K	0.14%	99
2025 Q3	$381K	Sell	786 -8	-1%	-$3.72K	0.13%	108
2025 Q2	$322K	Sell	794 -19	-2%	-$7.94K	0.12%	110
2025 Q1	$405K	Sell	813 -50	-6%	-$27.1K	0.17%	104
2024 Q4	$449K	Hold	863	–	–	0.2%	103
2024 Q3	$534K	Hold	863	–	–	0.24%	97
2024 Q2	$477K	Hold	863	–	–	0.27%	92
2024 Q1	$502K	Sell	863 -15	-2%	-$8.42K	0.29%	89
2023 Q4	$468K	Sell	878 -25	-3%	-$12.1K	0.28%	88
2023 Q3	$457K	Sell	903 -13	-1%	-$6.93K	0.31%	86
2023 Q2	$478K	Sell	916 -9	-1%	-$4.86K	0.31%	85
2023 Q1	$533K	Sell	925 -50	-5%	-$28.2K	0.35%	83
2022 Q4	$537K	Buy	+975	New	+$517K	0.39%	79

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Etesian Wealth Advisors's TMO Position: Q2 2026 in Review

Etesian Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 8.4% in Q2 2026, selling an estimated $30.7K and leaving 702 shares worth $352K. The position accounts for 0.1% of the portfolio, ranked #107.

Etesian Wealth Advisors first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $537K in Q4 2022. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Etesian Wealth Advisors held 702 shares of Thermo Fisher Scientific worth $352K as of Q2 2026.
Etesian Wealth Advisors sold 64 Thermo Fisher Scientific shares in Q2 2026, an estimated $30.7K.
Thermo Fisher Scientific made up 0.1% of Etesian Wealth Advisors's portfolio in Q2 2026, its #107 holding.
Etesian Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Etesian Wealth Advisors's Thermo Fisher Scientific position peaked at $537K in Q4 2022.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Etesian Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.